Torkildsen Ø - Search Results

1

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.

Røsjø E, Steffensen LH, Jørgensen L, Lindstrøm JC, Šaltytė Benth J, Michelsen AE, Aukrust P, Ueland T, Kampman MT, Torkildsen Ø, Holmøy T. Røsjø E, et al. Among authors: torkildsen o. J Neurol. 2015 Dec;262(12):2713-21. doi: 10.1007/s00415-015-7902-5. Epub 2015 Oct 1. J Neurol. 2015. PMID: 26429571 Clinical Trial.

2

Epstein-Barr virus reactivation and multiple sclerosis.

Torkildsen Ø, Nyland H, Myrmel H, Myhr KM. Torkildsen Ø, et al. Eur J Neurol. 2008 Jan;15(1):106-8. doi: 10.1111/j.1468-1331.2007.02009.x. Epub 2007 Nov 27. Eur J Neurol. 2008. PMID: 18042233

3

Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis.

Torkildsen Ø, Knappskog PM, Nyland HI, Myhr KM. Torkildsen Ø, et al. Arch Neurol. 2008 Jun;65(6):809-11. doi: 10.1001/archneur.65.6.809. Arch Neurol. 2008. PMID: 18541802

4

ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial.

Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Lilleås F, Pedersen T, Bjørnarå B, Dalene F, Kleveland G, Schepel J, Olsen IC, Myhr KM. Torkildsen O, et al. Arch Neurol. 2012 Aug;69(8):1044-51. doi: 10.1001/archneurol.2012.283. Arch Neurol. 2012. PMID: 22507886 Clinical Trial.

5

Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.

Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Sandvik L, Torkildsen O, Wergeland S, Myhr KM. Løken-Amsrud KI, et al. Among authors: torkildsen o. Neurology. 2012 Jul 17;79(3):267-73. doi: 10.1212/WNL.0b013e31825fdf01. Epub 2012 Jun 13. Neurology. 2012. PMID: 22700809

6

Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Holmøy T. Løken-Amsrud KI, et al. Among authors: torkildsen o. Mult Scler. 2013 Apr;19(4):451-7. doi: 10.1177/1352458512457843. Epub 2012 Aug 20. Mult Scler. 2013. PMID: 22907941

7

Fat-soluble vitamins as disease modulators in multiple sclerosis.

Torkildsen Ø, Løken-Amsrud KI, Wergeland S, Myhr KM, Holmøy T. Torkildsen Ø, et al. Acta Neurol Scand Suppl. 2013;(196):16-23. doi: 10.1111/ane.12045. Acta Neurol Scand Suppl. 2013. PMID: 23190287

8

Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.

Grytten N, Torkildsen Ø, Aarseth JH, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Kampman MT. Grytten N, et al. Among authors: torkildsen o. Mult Scler. 2013 Jul;19(8):1028-34. doi: 10.1177/1352458512471094. Epub 2012 Dec 20. Mult Scler. 2013. PMID: 23257620

9

Month of birth as a risk factor for multiple sclerosis: an update.

Torkildsen O, Grytten N, Aarseth J, Myhr KM, Kampman MT. Torkildsen O, et al. Acta Neurol Scand Suppl. 2012;(195):58-62. doi: 10.1111/ane.12040. Acta Neurol Scand Suppl. 2012. PMID: 23278658

10

Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.

Holmøy T, Torkildsen Ø, Myhr KM, Løken-Amsrud KI. Holmøy T, et al. Among authors: torkildsen o. Acta Neurol Scand Suppl. 2012;(195):63-9. doi: 10.1111/ane.12028. Acta Neurol Scand Suppl. 2012. PMID: 23278659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page